• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过获取和利用药物辅助治疗来改善公众健康。

Improving public health through access to and utilization of medication assisted treatment.

机构信息

Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Rockville, MD 20857, USA.

出版信息

Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24.

DOI:10.3390/ijerph8104102
PMID:22073031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3210600/
Abstract

Providing access to and utilization of medication assisted treatment (MAT) for the treatment of opioid abuse and dependence provides an important opportunity to improve public health. Access to health services comprising MAT in the community is fundamental to achieve broad service coverage. The type and placement of the health services comprising MAT and integration with primary medical care including human immunodeficiency virus (HIV) prevention, care and treatment services are optimal for addressing both substance abuse and co-occurring infectious diseases. As an HIV prevention intervention, integrated (same medical record for HIV services and MAT services) MAT with HIV prevention, care and treatment programs provides the best "one stop shopping" approach for health service utilization. Alternatively, MAT, medical and HIV services can be separately managed but co-located to allow convenient utilization of primary care, MAT and HIV services. A third approach is coordinated care and treatment, where primary care, MAT and HIV services are provided at distinct locations and case managers, peer facilitators, or others promote direct service utilization at the various locations. Developing a continuum of care for patients with opioid dependence throughout the stages MAT enhances the public health and Recovery from opioid dependence. As a stigmatized and medical disenfranchised population with multiple medical, psychological and social needs, people who inject drugs and are opioid dependent have difficulty accessing services and navigating medical systems of coordinated care. MAT programs that offer comprehensive services and medical care options can best contribute to improving the health of these individuals thereby enhancing the health of the community.

摘要

提供药物辅助治疗(MAT)的获取和利用,以治疗阿片类药物滥用和依赖,为改善公共卫生提供了重要机会。在社区中获得包括 MAT 的卫生服务,是实现广泛服务覆盖的基础。MAT 所包含的卫生服务的类型和定位,以及与初级医疗保健的整合,包括人类免疫缺陷病毒(HIV)的预防、护理和治疗服务,对于解决药物滥用和同时发生的传染病是最理想的。作为一种 HIV 预防干预措施,将 MAT 与 HIV 预防、护理和治疗计划进行整合(HIV 服务和 MAT 服务使用同一个病历),为卫生服务的利用提供了最佳的“一站式服务”方法。或者,MAT、医疗和 HIV 服务可以分别管理,但位于同一地点,以便方便利用初级保健、MAT 和 HIV 服务。第三种方法是协调护理和治疗,其中初级保健、MAT 和 HIV 服务在不同地点提供,而个案管理人员、同伴促进者或其他人员则在各个地点促进直接服务的利用。在 MAT 的各个阶段为阿片类药物依赖患者提供连续护理,可增强公共卫生和阿片类药物依赖的康复。由于注射毒品和阿片类药物依赖者是一个受到污名化和医疗剥夺权利的群体,他们有多种医疗、心理和社会需求,因此很难获得服务并在协调护理的医疗系统中进行导航。提供全面服务和医疗保健选择的 MAT 计划,可以为改善这些人的健康状况做出最大贡献,从而增强社区的健康。

相似文献

1
Improving public health through access to and utilization of medication assisted treatment.通过获取和利用药物辅助治疗来改善公众健康。
Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24.
2
The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.将药物辅助治疗阿片类药物成瘾与移动健康相结合的效果:一项随机临床试验的研究方案
Trials. 2016 Dec 12;17(1):592. doi: 10.1186/s13063-016-1726-1.
3
The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.初级保健在改善农村医疗补助计划参保者阿片类药物使用障碍患者获得药物辅助治疗方面的作用。
J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18.
4
Impact of Medication-Assisted Treatment for Opioid Addiction on Medicaid Expenditures and Health Services Utilization Rates in Vermont.药物辅助治疗阿片类药物成瘾对佛蒙特州医疗补助支出及医疗服务利用率的影响。
J Subst Abuse Treat. 2016 Aug;67:9-14. doi: 10.1016/j.jsat.2016.05.002. Epub 2016 May 9.
5
Tuberculosis结核病
6
Medication-assisted treatment for substance use disorders within a national community health center research network.国家社区卫生中心研究网络内针对物质使用障碍的药物辅助治疗。
Subst Abus. 2016 Oct-Dec;37(4):625-634. doi: 10.1080/08897077.2016.1189477.
7
Medication for addiction treatment and acute care utilization in HIV-positive adults with substance use disorders.针对患有物质使用障碍的HIV阳性成年人的成瘾治疗药物及急性护理利用情况。
AIDS Care. 2020 Sep;32(9):1177-1181. doi: 10.1080/09540121.2019.1683805. Epub 2019 Nov 5.
8
Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.用于阿片类药物成瘾的药物辅助治疗(MAT):特刊介绍
Subst Use Misuse. 2018 Jan 28;53(2):177-180. doi: 10.1080/10826084.2017.1404106. Epub 2017 Dec 8.
9
Patient predictors of substance use disorder treatment initiation in primary care.患者预测因素在初级保健中物质使用障碍治疗的启动。
J Subst Abuse Treat. 2018 Jul;90:64-72. doi: 10.1016/j.jsat.2018.04.004. Epub 2018 Apr 28.
10
Predictors of Medication Utilization for Opioid Use Disorder Among Medicaid-Insured HIV Patients in New York.纽约州医疗补助保险的 HIV 患者阿片类药物使用障碍药物使用的预测因素。
Am J Addict. 2020 Mar;29(2):151-154. doi: 10.1111/ajad.12998. Epub 2020 Jan 17.

引用本文的文献

1
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.舌下含服和缓释丁丙诺啡治疗的留存率与退出率:来自美国具有商业保险的阿片类药物使用障碍患者全国代表性样本数据的比较分析
Int J Drug Policy. 2025 Apr;138:104748. doi: 10.1016/j.drugpo.2025.104748. Epub 2025 Feb 27.
2
Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators.问题解决法庭中的药物辅助治疗:对州和地方法庭协调员的全国性调查。
J Drug Issues. 2023 Apr;53(2):296-320. doi: 10.1177/00220426221109948. Epub 2022 Aug 2.
3
Awareness and willingness to use HIV oral pre-exposure prophylaxis among people who inject drugs in Dar es Salaam, Tanzania: A cross-sectional survey.坦桑尼亚达累斯萨拉姆注射吸毒者对艾滋病毒口服暴露前预防的知晓率和使用意愿:一项横断面调查。
PLOS Glob Public Health. 2022 Nov 22;2(11):e0000776. doi: 10.1371/journal.pgph.0000776. eCollection 2022.
4
Awareness, perception and utilization of a mobile health clinic by people who use drugs.吸毒者对移动医疗诊所的认知、感知和利用。
Ann Med. 2022 Dec;54(1):138-149. doi: 10.1080/07853890.2021.2022188.
5
Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico.波多黎各农村地区注射吸毒者阿片类激动剂治疗的治疗轨迹和障碍。
J Subst Abuse Treat. 2021 Aug;127:108347. doi: 10.1016/j.jsat.2021.108347. Epub 2021 Mar 3.
6
Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.接受医疗补助计划(Medicaid)参保者并接受丁丙诺啡处方培训的妇产科医生的流行率和地理分布。
JAMA Netw Open. 2020 Dec 1;3(12):e2029043. doi: 10.1001/jamanetworkopen.2020.29043.
7
Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study.2017 - 2018年联邦处方政策变化后丁丙诺啡处方配药率及特征:一项横断面研究。
Drug Alcohol Depend. 2020 Aug 1;213:108083. doi: 10.1016/j.drugalcdep.2020.108083. Epub 2020 May 25.
8
Structural Determinants of Black MSM HIV Testing Coverage (2011-2016).结构性因素对黑人性少数男性艾滋病毒检测覆盖率的影响(2011-2016 年)。
AIDS Behav. 2020 Sep;24(9):2572-2587. doi: 10.1007/s10461-020-02814-4.
9
Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.1993-2007 年美国 90 个大都市区注射吸毒者药物治疗覆盖率变化的预测因素。
Subst Abuse Treat Prev Policy. 2020 Jan 9;15(1):3. doi: 10.1186/s13011-019-0235-0.
10
ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder.美国医学毒理学学会立场声明:取消开具丁丙诺啡治疗阿片类物质使用障碍的豁免要求。
J Med Toxicol. 2019 Oct;15(4):307-309. doi: 10.1007/s13181-019-00728-9. Epub 2019 Aug 14.

本文引用的文献

1
Hepatitis infection in the treatment of opioid dependence and abuse.肝炎感染在阿片类药物依赖和滥用治疗中的情况。
Subst Abuse. 2008 Apr 28;1:15-61. doi: 10.4137/sart.s580. eCollection 2008.
2
Correlates of alcohol abuse/dependence in early-onset alcohol-using women.早发性饮酒女性中酒精滥用/依赖的相关因素。
Am J Addict. 2011 Sep-Oct;20(5):429-34. doi: 10.1111/j.1521-0391.2011.00151.x. Epub 2011 Jul 18.
3
Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample.前瞻性研究 ADHD 症状与人群样本中物质使用发展的关系。
Psychol Med. 2011 Dec;41(12):2615-23. doi: 10.1017/S0033291711000791. Epub 2011 May 20.
4
How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.处方类阿片使用者与海洛因或其他药物使用者在精神病理学方面有何不同:来自国家酒精和相关条件流行病学调查的结果。
J Addict Med. 2011 Mar;5(1):28-35. doi: 10.1097/ADM.0b013e3181e0364e.
5
Contributions of serotonin in addiction vulnerability.血清素在成瘾易感性中的作用。
Neuropharmacology. 2011 Sep;61(3):421-32. doi: 10.1016/j.neuropharm.2011.03.022. Epub 2011 Apr 3.
6
A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care.一种联邦合作模式,旨在增加艾滋病毒初级保健中丁丙诺啡治疗的患者可及性。
J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S3-6. doi: 10.1097/QAI.0b013e318209740f.
7
Individual and network factors associated with non-fatal overdose among rural Appalachian drug users.农村阿巴拉契亚地区吸毒者非致命性药物过量的个体和网络因素。
Drug Alcohol Depend. 2011 May 1;115(1-2):107-12. doi: 10.1016/j.drugalcdep.2010.11.003. Epub 2010 Dec 3.
8
High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors).在德克萨斯州圣安东尼奥市,墨西哥裔美国的非注射用海洛因使用者(从未使用过和曾经使用过的)中,过渡到注射吸毒的比例很高。
Drug Alcohol Depend. 2011 Apr 1;114(2-3):233-6. doi: 10.1016/j.drugalcdep.2010.09.014. Epub 2010 Nov 13.
9
Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.传染病合并症对感染 HIV 的物质使用者有不良影响:丙型肝炎和结核病。
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(0 1):S37-42. doi: 10.1097/QAI.0b013e3181f9c0b6.
10
Drug treatment as HIV prevention: a research update.药物治疗作为 HIV 预防:研究进展。
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S32-6. doi: 10.1097/QAI.0b013e3181f9c10b.